The Journal of ExtraCorporeal Technology No 56-4 | Page 26

164 N . Kachoueian et al .: J Extra Corpor Technol 2024 , 56 , 159 – 166
Table 3 . Frequency distribution of cardiac enzymes among patients of both groups , LR DN ( modified del Nido ) and PL DN groups ( conventional del Nido solution ), at different measurement points .
Groups
LR DN
PL DN
p-value
Variables
( mean ± SD )
( mean ± SD )
Preoperative
CPK ( ng / mL )
111 ± 117
101 ± 187.25
0.32
cTnI ( ng / mL )
1.6 ± 4.79
1.52 ± 2.68
0.81
Post-declamp
CPK ( ng / mL )
233 ± 314.85
248 ± 112
0.71
cTnI ( ng / mL )
1.85 ± 4.22
1.92 ± 2.82
0.24
ICU admission
CPK ( ng / mL )
390 ± 351
383.50 ± 160.75
0.22
cTnI ( ng / mL )
2.20 ± 3.54
2.15 ± 2.60
0.005 #
24 h after ICU admission
CPK ( ng / mL )
437 ± 215
270.50 ± 199.25
0.18
cTnI ( ng / mL )
2.26 ± 3.90
1.79 ± 1.03
0.03
CPK : creatine phosphokinase , CPK-MB : creatine phosphokinase-MB , LDH : lactate dehydrogenase , cTnI : cardiac troponin I , ICU : intensive care unit , IQR : interquartile range . # There is a significant difference between groups ( p < 0.05 ).
Table 4 . Frequency distribution of blood product usage among patients of both groups , LR DN ( modified del Nido ) and PL DN groups ( conventional del Nido solution ), at different measurement points .
Groups LR DN PL DN p-value Variables N % N %
Operation room
Pack cell
14
24.6
12
23.1
0.856
Platelet
12
21.1
8
15.4
0.445
FFP
10
17.5
12
23.1
0.47
Fibrinogen
0
0
1
1.9
0.293
ICU admission
Pack cell
8
14
11
21.2
0.33
Platelet
3
5.3
5
9.6
0.384
FFP
3
5.3
2
3.8
0.724
n stands for the frequency of the patients receiving that product in each group and the % for the frequency percent of the patients in each group receiving that product at the corresponding time . ICU : intensive care unit , FFP : fresh frozen plasma .
Table 5 . Values of arterial blood gasses among patients of both groups , LR DN ( modified del Nido ) and PL DN groups ( conventional del Nido solution ), at different measurement points .
Groups
LR DN
PL DN
p-value
Variables
( mean ± SD )
( mean ± SD )
Preoperative
PaO 2 ( mm Hg )
343 ± 251
363.50 ± 218.25
0.54
PaCO 2 ( mm Hg )
39 ± 2
39 ± 2.75
0.84
HCO 3 ( mm Hg )
27 ± 4
26 ± 34
0.81
Postoperative
PaO 2 ( mm Hg )
281.50 ± 209.50
314 ± 145
0.86
PaCO 2 ( mm Hg )
39 ± 8
37 ± 5
0.15
HCO 3 ( mm Hg )
22 ± 3.75
23 ± 2
0.21
ICU admission
PaO 2 ( mm Hg )
157 ± 99
136 ± 70.75
0.24
PaCO 2 ( mm Hg )
41 ± 9
41 ± 6.50
0.45
HCO 3 ( mm Hg )
23 ± 3.50
22 ± 4.50
0.96
ICU : intensive care unit , PaO 2 : partial pressure of oxygen ; PaCO 2 : partial pressure of carbon dioxide ; HCO 3 : bicarbonate , IQR : interquartile range . The fraction of inspired oxygen , FiO2 , was 90 % according to the standard of practice in our setting .
Study limitations
Interpretation of the findings from the current study is limited by the small sample size . Also , the current study follows up on the patients until 24 h after ICU admission . Studies with longer follow-up time , in the ICU and post-discharge from the hospital , may give better insights into the long-term outcomes of using LR as a substitute with PL as a base solution in the DN cardioplegia .
Conclusion
In conclusion , based on the significantly higher serum levels of cTnI and the higher need for inotrope at the postoperative and ICU stay measurement points in patients receiving modified DN solution , We recommend using standard del Nido cardioplegia with a base of Plasma-Lyte A for patients presenting for CABG surgery regarding its better myocardial protection in the present study . Further studies are warranted to